Human papillomavirus (HPV) vaccines work by preventing infections prior to natural
exposure. Thus, it is likely more effective at younger ages, and it is important to understand …

Introduction Human papillomavirus (HPV) infection, which poses significant disease burden,
is decreasing following implementation of vaccination programs. Synthesized evidence on …

Background The primary goal of human papillomavirus (HPV) vaccination is to reduce
morbidity and mortality from HPV-associated disease, especially cervical cancer. We …

Aim Prophylactic human papillomavirus (HPV) vaccines are highly effective at preventing
pre–cancerous cervical lesions when given in a three–dose schedule. Some post–hoc trial …

Background Human papillomavirus (HPV) vaccines were first licensed as a three-dose
series. Two doses are now widely recommended in some age groups; there are data …

Background Vaccination against human papillomavirus (HPV) has proven to be effective
against severe cervical lesions and genital warts, whereas no previous study has provided …

Background Highly effective human papillomavirus (HPV) vaccines are used in many
national programs in 3-or 2-dose schedules. We examined HPV vaccine effectiveness …

Background A reduced, 2-dose schedule of human papillomavirus (HPV) vaccination has
been endorsed for preadolescent women on the basis of immunogenicity data from …

Objective To assess the benefits and harms of the human papillomavirus (HPV) vaccines.
Data sources Clinical study reports obtained from the European Medicines Agency and …

Aim: This study aimed to follow the impact of human papillomavirus (HPV) catch-up and
vaccination on the very high cervical HPV-prevalence in women at a youth clinic in central …